Stock Events

Stock Events

Sona Nanotech 

$0.2420
9
-$0.01-3.2% Monday 20:00

Statistics

Day High
0.25
Day Low
0.25
52W High
0.59
52W Low
0.187
Volume
9,000
Avg. Volume
5,320
Mkt Cap
27.68M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24SepExpected
Q1 2021
Q4 2024
Q1 2025
Q2 2025
Q1 2026
Q1 2026
Next
-0.03
-0.02
-0.01
-0.01
Expected EPS
-0.0099292712
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-2.31MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNANF. It's not an investment recommendation.
Enbridge
2
ENB.TO
iShares Core Equity Portfolio
2
XEQT.TO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories develops diagnostic technologies similar to Sona Nanotech's rapid testing solutions.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a range of diagnostic and research tools that compete in the same space as Sona Nanotech.
QuidelOrtho
QDEL
Mkt Cap1.01B
Quidel Corporation specializes in diagnostic healthcare products that overlap with Sona Nanotech's market.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories, Inc. produces diagnostic products and complex biotechnological products that compete with Sona Nanotech.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics incorporates diagnostic testing, including COVID-19 tests, which competes with Sona Nanotech's offerings.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates in the same clinical and diagnostic testing field as Sona Nanotech.
Agilent Technologies
A
Mkt Cap43.38B
Agilent Technologies provides analytical instruments and services that are used in labs like those that would use Sona Nanotech products.
Bruker
BRKR
Mkt Cap8.7B
Bruker Corporation designs and manufactures scientific instruments and diagnostic assays, competing with Sona Nanotech's technologies.

About

Sona Nanotech Inc. is a life sciences enterprise specializing in nanotechnology, primarily engaged in the development and commercialization of gold nanorod products for diagnostic purposes. The company's offerings also encompass distinct gold nanorod varieties, such as Gemini and Omni (the latter tailored specifically for medical uses), alongside providing specialized contract services. A prominent product is their Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic test designed to identify SARS-CoV-2 spike protein antigens within saliva samples from individuals suspected of COVID-19 infection. These advanced gold nanorod technologies are utilized in a diverse array of applications, including targeted drug delivery, analytical testing for food, beverages, and environmental contaminants, cellular imaging, cancer treatment, liposuction therapy, and various diagnostic fields spanning human medicine, consumer goods, military applications, and veterinary science. The company's headquarters are located in Halifax, Canada.
Show more...
CEO
David Andrew Regan
Employees
8
Country
Canada
ISIN
CA83541C1059

Listings

CN
CA
SONA.CN
OTC Link
US
SNANF

0 Comments

Share your thoughts

FAQ

What is Sona Nanotech stock price today?▼
The current price of SNANF is $0.24 USD — it has decreased by -3.2% in the past 24 hours. Watch Sona Nanotech stock price performance more closely on the chart.
What is Sona Nanotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Sona Nanotech stocks are traded under the ticker SNANF.
Is Sona Nanotech stock price growing?▼
SNANF stock has fallen by -3.2% compared to the previous week, the month change is a +10% rise, over the last year Sona Nanotech has showed a -46.04% decrease.
What is Sona Nanotech market cap?▼
Today Sona Nanotech has the market capitalization of 27.68M
When is the next Sona Nanotech earnings date?▼
Sona Nanotech is going to release the next earnings report on September 24, 2026.
What were Sona Nanotech earnings last quarter?▼
SNANF earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.01 USD resulting in a +28.2% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sona Nanotech revenue for the last year?▼
Sona Nanotech revenue for the last year amounts to 0 USD.
What is Sona Nanotech net income for the last year?▼
SNANF net income for the last year is -2.31M USD.
How many employees does Sona Nanotech have?▼
As of September 04, 2026, the company has 8 employees.
In which sector is Sona Nanotech located?▼
Sona Nanotech operates in the Health & Wellness sector.
When did Sona Nanotech complete a stock split?▼
Sona Nanotech has not had any recent stock splits.
Where is Sona Nanotech headquartered?▼
Sona Nanotech is headquartered in Halifax, Canada.